Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been given a $60.00 target price by research analysts at Jefferies Group LLC in a research report issued to clients and investors on Wednesday. The brokerage presently has a “buy” rating on the stock. Jefferies Group LLC’s target price would suggest a potential upside of 38.57% from the company’s current price. Jefferies Group also issued estimates for Acadia Healthcare’s Q4 2017 earnings at $0.68 EPS and FY2017 earnings at $2.45 EPS.
Other analysts also recently issued research reports about the company. Zacks Investment Research downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday. Mizuho lifted their price objective on Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. Craig Hallum reaffirmed a “buy” rating and issued a $65.00 price objective (up previously from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Deutsche Bank AG boosted their target price on Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, July 31st. Finally, UBS AG reissued a “positive” rating and set a $60.00 target price (up previously from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $57.40.
Shares of Acadia Healthcare (NASDAQ ACHC) opened at 43.30 on Wednesday. The firm has a 50-day moving average price of $46.21 and a 200 day moving average price of $46.34. The stock has a market cap of $3.80 billion, a price-to-earnings ratio of 475.82 and a beta of 1.07. Acadia Healthcare has a 52 week low of $32.54 and a 52 week high of $54.34.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The business had revenue of $715.90 million for the quarter, compared to the consensus estimate of $717.38 million. During the same quarter in the previous year, the company posted $0.73 EPS. The company’s revenue was down 5.4% compared to the same quarter last year. On average, analysts forecast that Acadia Healthcare will post $2.45 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Acadia Healthcare Company, Inc. (ACHC) Given a $60.00 Price Target by Jefferies Group LLC Analysts” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2017/10/13/acadia-healthcare-company-inc-achc-given-a-60-00-price-target-by-jefferies-group-llc-analysts.html.
In related news, President Brent Turner sold 206,252 shares of the business’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the completion of the transaction, the president now owns 81,106 shares in the company, valued at approximately $4,111,263.14. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Christopher L. Howard sold 53,713 shares of the business’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the transaction, the executive vice president now owns 147,286 shares of the company’s stock, valued at approximately $7,465,927.34. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 3,085,693 shares of company stock valued at $157,729,099. 11.10% of the stock is owned by company insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Teacher Retirement System of Texas boosted its holdings in Acadia Healthcare by 0.4% during the 2nd quarter. Teacher Retirement System of Texas now owns 5,949 shares of the company’s stock valued at $294,000 after acquiring an additional 26 shares during the period. Public Employees Retirement Association of Colorado boosted its holdings in Acadia Healthcare by 0.9% during the 2nd quarter. Public Employees Retirement Association of Colorado now owns 17,798 shares of the company’s stock valued at $879,000 after acquiring an additional 160 shares during the period. Pacer Advisors Inc. boosted its holdings in Acadia Healthcare by 2.2% during the 2nd quarter. Pacer Advisors Inc. now owns 10,365 shares of the company’s stock valued at $512,000 after acquiring an additional 226 shares during the period. People s United Financial Inc. boosted its holdings in Acadia Healthcare by 3.4% during the 2nd quarter. People s United Financial Inc. now owns 7,459 shares of the company’s stock valued at $368,000 after acquiring an additional 242 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Acadia Healthcare by 11.1% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after acquiring an additional 270 shares during the period.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
What are top analysts saying about Acadia Healthcare Company Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Acadia Healthcare Company Inc. and related companies.